| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.03. | ATOMO DIAGNOSTICS LIMITED: Change in substantial holding | - | ASX | ||
| 30.03. | ATOMO DIAGNOSTICS LIMITED: Update - Proposed issue of securities - AT1 | - | ASX | ||
| 30.03. | Atomo Diagnostics Completes $4 Million Capital Raise | 1 | Finance News Network | ||
| 30.03. | ATOMO DIAGNOSTICS LIMITED: Proposed issue of securities - AT1 | - | ASX | ||
| ATOMO DIAGNOSTICS Aktie jetzt für 0€ handeln | |||||
| 30.03. | ATOMO DIAGNOSTICS LIMITED: Proposed issue of securities - AT1 | - | ASX | ||
| 29.03. | ATOMO DIAGNOSTICS LIMITED: Atomo Completes Capital Raise | - | ASX | ||
| 29.03. | ATOMO DIAGNOSTICS LIMITED: FebriDx FDA CLIA wavier approval unlocks upside for Pascal | - | ASX | ||
| 26.03. | ATOMO DIAGNOSTICS LIMITED: Trading Halt | 1 | ASX | ||
| 25.03. | ATOMO DIAGNOSTICS LIMITED: Pause in Trading | - | ASX | ||
| 25.03. | ATOMO DIAGNOSTICS LIMITED: Response to ASX Price Query | 2 | ASX | ||
| 25.03. | ATOMO DIAGNOSTICS LIMITED: Pause in Trading | 1 | ASX | ||
| 25.02. | ATOMO DIAGNOSTICS LIMITED: H1 FY26 Results Presentation | - | ASX | ||
| 25.02. | ATOMO DIAGNOSTICS LIMITED: Appendix 4D and Half Year Report ended 31 Dec 2025 | - | ASX | ||
| 22.02. | ATOMO DIAGNOSTICS LIMITED: Investor Webinar Presentation | - | ASX | ||
| 05.02. | ATOMO DIAGNOSTICS LIMITED: Atomo Secures Australian Order for Supply of HIV Self-Tests | - | ASX | ||
| 29.01. | ATOMO DIAGNOSTICS LIMITED: Atomo Secures a Significant Order for HIV Self-Test | - | ASX | ||
| 28.01. | Atomo Diagnostics Q2 FY26 slides: revenue doubles as product portfolio expands | 1 | Investing.com | ||
| 27.01. | ATOMO DIAGNOSTICS LIMITED: Quarterly Activities/Appendix 4C Cash Flow Report | - | ASX | ||
| 22.01. | ATOMO DIAGNOSTICS LIMITED: Atomo Investor Webinar Presentation | - | ASX | ||
| 19.01. | ATOMO DIAGNOSTICS LIMITED: Exclusive Licence for a Novel Liver Function Test on Pascal | - | ASX |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|